Spectrum of Pleural Fluid Cytology in a Tertiary Care Hospital: A Prospective Observational Study
DOI:
https://doi.org/10.21276/apalm.3699Keywords:
the international system for reporting serous fluid cytopathology, pleural effusion cytology, pleural fluid, risk of malignancyAbstract
Background: Pleural effusion (PE) is a frequent clinical finding with a wide spectrum of underlying etiologies, including infections, malignancies, and systemic disorders. Cytological examination of pleural fluid remains a valuable first-line diagnostic tool, offering rapid, minimally invasive, and cost-effective results. The adoption of standardized reporting frameworks such as The International System for Reporting Serous Fluid Cytopathology (ISRSFC/TIS) enhances diagnostic clarity and consistency.
Methods: This was a prospective observational study conducted at a tertiary care hospital. A total of 155 pleural fluid samples were evaluated using cytological analysis and classified according to the TIS system. Patient demographics, sample adequacy, fluid appearance, predominant cellular patterns, and final cytological diagnoses were recorded and interpreted.
Results: Out of 155 samples, mean age of patients was 49.93 years, with male predominance (62.6%). Straw-colored fluid was the most common macroscopic presentation (41.9%). Cytological, chronic inflammation with lymphocyte dominance was observed in 68.4% of cases. Malignant cells were identified in three cases (1.9%). Using the TIS classification, 92.9% of samples were categorized as Category II: Negative for Malignancy (NFM), facilitating standardized reporting system.
Conclusion: Cytological examination of pleural fluid remains a valuable initial diagnostic tool for evaluating serous effusions. Incorporating the TIS system enhances diagnostic accuracy and consistency, thereby supporting timely clinical decision-making and improved patient outcomes.
References
1. Krishna R, Antoine MH, Alahmadi MH, Rudrappa M. Pleural Effusion. In Treasure Island (FL); 2025.
2. S. Laxma Reddy, K. Varaprasad, Narendrakumar Narahari, K. Bhaskar, G. Rajashekar Varma GKP. Clinical and Etiological Profile of an Exudative Pleural Effusion in a Tertiary Care Center. Indian J Respir Care. 2019;8(1).
3. Saini N, Ahluwalia S, Ahluwalia S, Selhi PK, Singh A. Spectrum and outcome in patients with unilateral pleural effusion admitted in a tertiary care hospital. J Clin Sci Res (Internet). 2022;11(2). Available from: https://journals.lww.com/jcsr/fulltext/2022/11020/spectrum_and_outcome_in_patients_with_unilateral.2.aspx
4. Mercer RM, Corcoran JP, Porcel JM, Rahman NM, Psallidas I. Interpreting pleural fluid results . Clin Med. 2019 May;19(3):213–7.
5. Yang Y, Du J, Wang YS, Kang HY, Zhai K, Shi HZ. Prognostic impact of pleural effusion in patients with malignancy: A systematic review and meta-analysis. Clin Transl Sci. 2022 Jun;15(6):1340–54.
6. Rakha EA, Patil S, Abdulla K, Abdulkader M, Chaudry Z, Soomro IN. The sensitivity of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma. Diagn Cytopathol. 2010 Dec;38(12):874–9.
7. Batra H, Antony VB. Pleural mesothelial cells in pleural and lung diseases. J Thorac Dis. 2015 Jun;7(6):964–80.
8. Sapna Dhakad, Amit Niranjan, Neeraj Pancholi RB. Study of Pleural Fluid Cytology in a Tertiary Care Hospital. Int J Sci Res. 2023;12(9).
9. Biswas B, Sharma SK, Negi RS, Gupta N, Jaswal VMS, Niranjan N. Pleural effusion: Role of pleural fluid cytology, adenosine deaminase level, and pleural biopsy in diagnosis. J Cytol. 2016;33(3):159–62.
10. Loveland P, Christie M, Hammerschlag G, Irving L, Steinfort D. Diagnostic yield of pleural fluid cytology in malignant effusions: an Australian tertiary centre experience. Intern Med J. 2018 Nov;48(11):1318–24.
11. Shikha Ngairangbam DBB. CYTOLOGICAL STUDY OF PLEURAL FLUIDS AND ITS CLINICOBIOCHEMICAL CORRELATION. J Evid based Med Healthc. 2015;2(44):7880–5.
12. Canan Sadullahoğlu RU. Role of Cytology in Pleural Effusion: A Single-Center Experience. Erciyes Med J. 2019;4(41):409–13.
13. Kassirian S, Hinton SN, Cuninghame S, Chaudhary R, Iansavitchene A, Amjadi K, Dhaliwal I, Zeman-Pocrnich C, Mitchell MA. Diagnostic sensitivity of pleural fluid cytology in malignant pleural effusions: systematic review and meta-analysis. Thorax. 2023 Jan;78(1):32–40.
14. Wang M, Chandra A, Cai G. The International System for Reporting Serous Fluid Cytopathology-An Updated Review. J Clin Transl Pathol. 2023;3(4):160–77.
15. Kapoor S, Samanta S, Kaur K. Role of Ancillary Techniques in Reporting Serous Fluid Cytology - “Redefining Categories, Refining Diagnosis”. J Cytol. 2024;41(2):96–104.
16. Pinto D, Chandra A, Crothers BA, Kurtycz DFI, Schmitt F. The international system for reporting serous fluid cytopathology-diagnostic categories and clinical management. J Am Soc Cytopathol. 2020;9(6):469–77.
17. Jha S, Sethy M, Adhya AK. Application of the International System for Reporting Serous Fluid Cytopathology in routine reporting of pleural effusion and assessment of the risk of malignancy. Diagn Cytopathol. 2021 Oct;49(10):1089–98.
18. Pergaris A, Stefanou D, Keramari P, Sousouris S, Kavantzas N, Gogas H, Mikou P. Application of the International System for Reporting Serous Fluid Cytopathology with Cytohistological Correlation and Risk of Malignancy Assessment. Diagnostics (Basel, Switzerland). 2021 Nov;11(12).
19. Straccia P, Chiappetta M, Magnini D, Cancellieri A. Application of the International System for Reporting Serous Fluid Cytopathology (TIS): A retrospective institutional study. Cytopathology. 2022 May;33(3):305–11.
20. Lu CH, Liu CY, Jhuang JY, Chen CC. Comprehensive evaluation of benign and malignant etiologies of different serous effusions with the International System for Reporting Serous Fluid Cytopathology: A multi-institutional study in Taiwan. Cancer Cytopathol. 2024 Mar;132(3):169–78.
21. Shen Y, Gosnell JM, Nawgiri R, Muthukumarana V. Application of the newly published International System for Reporting Serous Fluid Cytopathology in atypical and suspicious diagnosis: a four-year retrospective analysis. J Am Soc Cytopathol. 2024;13(4):303–8.
22. Kolte S, Zaheer S, Aden D, Ranga S. Application of the international system for reporting serous fluid cytopathology on reporting various body fluids; experience of a tertiary care hospital. Cytojournal. 2022;19:52.
23. Lekha M, Manjunatha Y. Analysis of Pleural fluid cytology: A one year study in tertiary care centre (Internet). Vol. 2020, IP Archives of Cytology and Histopathology Research. IP Innovative Publication ; 2020. p. 12439. Available from: https://www.achr.co.in/article-details/12439
24. Pairman L, Beckert LEL, Dagger M, Maze MJ. Evaluation of pleural fluid cytology for the diagnosis of malignant pleural effusion: a retrospective cohort study. Intern Med J. 2022 Jul;52(7):1154–9.
25. Gupta R, Gupta A, Ilyas M. Spectrum of Pleural Effusion Etiology Revisited in 18–70 Years of Age Group: A Tertiary Care Center-based Study of 1000 Patients. CHRISMED J Heal Res (Internet). 2018;5(2). Available from: https://journals.lww.com/chri/fulltext/2018/05020/spectrum_of_pleural_effusion_etiology_revisited_in.6.aspx
26. Ozcakar B, Martinez CH, Morice RC, Eapen GA, Ost D, Sarkiss MG, Chiu HT, Jimenez CA. Does pleural fluid appearance really matter? The relationship between fluid appearance and cytology, cell counts, and chemical laboratory measurements in pleural effusions of patients with cancer. J Cardiothorac Surg. 2010 Aug;5:63.
27. Priya D, Baalu S, Malathi M, Ashwini N, Soumya A. Spectrum of uncommon malignancies in pleural fluid cytology: A study from a tertiary care center in South India (Internet). Vol. 2021, Indian Journal of Pathology and Oncology. IP Innovative Publication ; 2021. p. 13264. Available from: https://www.ijpo.co.in/article-details/13264
28. Bharti S, Nalwa A, Elhence PA, Rao M, Bharti JN, Khera S, Vedant D, Vishwajeet V, Goel A. Risk Stratification of Pleural Fluid Cytology Based on the International System for Reporting Serous Fluid Cytology in a Tertiary Care Centre. Acta Cytol. 2022;66(5):449–56.
29. Castilho da Silva DJ, Dos Santos CR, Xavier-Júnior JCC. Risk of Malignancy in Effusions according to the International System for Serous Fluid Cytopathology: A Review. Acta Cytol. 2024;68(4):384–93.
30. Veerapaneni S, Radhika C, Prabhu M. Cytological approach for pleural fluid analysis – One year study (Internet). Vol. 2020, IP Archives of Cytology and Histopathology Research. IP Innovative Publication ; 2020. p. 11440. Available from: https://www.achr.co.in/article-details/11440
31. Saravanakumar P BJ. Morphological spectrum of effusion cytology in a tertiary care hospital. Int J Clin Diagnostic Pathol. 2021;1(4):151–3.
32. Zhu YL, Ren WH, Wang Q, Jin HZ, Guo YY, Lin DM. A retrospective analysis of serous effusions based on the newly proposed international system for reporting serous fluid cytopathology: a report of 3633 cases in an oncological center. Diagn Pathol. 2022 Jul;17(1):56.
33. Sunita G, Nilay S. Study of pleural fluid cytology in a tertiary care hospital (Internet). Vol. 2019, IP Archives of Cytology and Histopathology Research. IP Innovative Publication ; 2019. p. 8511. Available from: https://www.achr.co.in/article-details/8511
34. Xu Y, Hu AY, Wang SM, Wang Q, Pan YC, Zhang SH. A retrospective analysis of pleural effusion specimens based on the newly proposed International System for Reporting Serous Fluid Cytopathology. Diagn Cytopathol. 2021 Sep;49(9):997–1007.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Sakshi Sharma, Vishesh Dhawan, Ayushi Kediya, Anshul Kedia
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access at http://opcit.eprints.org/oacitation-biblio.html).
How to Cite
